Warberg Asset Management’s Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 CMRAW Stock Holding History

Warberg Asset Management’s Portfolio CMRAW Stock Details CMRAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-300,000	Closed	-$6.51K	–	284
2023 Q3	$6.51K	Hold	300,000	–	–	﹤0.01%	192
2023 Q2	$8.16K	Hold	300,000	–	–	﹤0.01%	187
2023 Q1	$13.7K	Sell	300,000 -5,440	-2%	-$269	﹤0.01%	182
2022 Q4	$14.6K	Hold	305,440	–	–	﹤0.01%	190
2022 Q3	$17K	Buy	305,440 +103,440	+51%	+$10.2K	﹤0.01%	213
2022 Q2	$29K	Buy	+202,000	New	+$33.1K	0.01%	169

Other funds holding CMRAW

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Warberg Asset Management's CMRAW Position: Q4 2023 in Review

Warberg Asset Management sold out of Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 (CMRAW) in Q4 2023, closing a stake of 300,000 shares — an estimated $6.51K sold.

Warberg Asset Management first reported a position in CMRAW in Q2 2022 and held it in 6 quarters. The position peaked at $29K in Q2 2022. 3 funds tracked by Wall St. Rank hold CMRAW as of Q4 2023.

Warberg Asset Management reported no remaining Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 position as of Q4 2023 after selling out during the quarter.
Warberg Asset Management sold 300,000 Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 shares in Q4 2023, an estimated $6.51K.
Warberg Asset Management first reported a position in Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 in Q2 2022 and held it in 6 quarters.
Warberg Asset Management's Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 position peaked at $29K in Q2 2022.
3 funds tracked by Wall St. Rank held Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 as of Q4 2023.

Based on Warberg Asset Management's 13F filing for Q4 2023, filed 7 Feb 2024.